Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Monitoring of Neutrophil Recruitment to Mice Lungs During Pneumonic Plague.

Vagima Y, Levy Y, Mamroud E.

Methods Mol Biol. 2019;2010:141-150. doi: 10.1007/978-1-4939-9541-7_10.

PMID:
31177436
2.

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system.

Tidhar A, Levy Y, Zauberman A, Vagima Y, Gur D, Aftalion M, Israeli O, Chitlaru T, Ariel N, Flashner Y, Zvi A, Mamroud E.

PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007449. doi: 10.1371/journal.pntd.0007449. eCollection 2019 Jun.

3.

Post-exposure administration of a Yersinia pestis live vaccine potentiates second-line antibiotic treatment against pneumonic plague.

Zauberman A, Gur D, Levy Y, Aftalion M, Vagima Y, Tidhar A, Chitlaru T, Mamroud E.

J Infect Dis. 2019 May 16. pii: jiz260. doi: 10.1093/infdis/jiz260. [Epub ahead of print]

PMID:
31095689
4.

A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers.

Shifman O, Steinberger-Levy I, Aloni-Grinstein R, Gur D, Aftalion M, Ron I, Mamroud E, Ber R, Rotem S.

Front Microbiol. 2019 Apr 16;10:754. doi: 10.3389/fmicb.2019.00754. eCollection 2019.

5.

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague.

Levy Y, Vagima Y, Tidhar A, Aftalion M, Gur D, Nili U, Chitlaru T, Zauberman A, Mamroud E.

NPJ Vaccines. 2018 Oct 19;3:52. doi: 10.1038/s41541-018-0087-z. eCollection 2018.

6.

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.

Gur D, Glinert I, Aftalion M, Vagima Y, Levy Y, Rotem S, Zauberman A, Tidhar A, Tal A, Maoz S, Ber R, Pass A, Mamroud E.

Front Microbiol. 2018 Apr 24;9:741. doi: 10.3389/fmicb.2018.00741. eCollection 2018.

7.

Simultaneous Immunodetection of Anthrax, Plague, and Tularemia from Blood Cultures by Use of Multiplexed Suspension Arrays.

Mechaly A, Vitner E, Levy H, Weiss S, Bar-David E, Gur D, Koren M, Cohen H, Cohen O, Mamroud E, Fisher M.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01479-17. doi: 10.1128/JCM.01479-17. Print 2018 Apr.

8.

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague.

Zauberman A, Vagima Y, Tidhar A, Aftalion M, Gur D, Rotem S, Chitlaru T, Levy Y, Mamroud E.

Front Cell Infect Microbiol. 2017 Jun 21;7:277. doi: 10.3389/fcimb.2017.00277. eCollection 2017.

9.

Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.

Zvi A, Rotem S, Zauberman A, Elia U, Aftalion M, Bar-Haim E, Mamroud E, Cohen O.

Vaccine. 2017 Oct 20;35(44):5995-6006. doi: 10.1016/j.vaccine.2017.05.092. Epub 2017 Jun 9.

PMID:
28606812
10.

Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.

Levy Y, Vagima Y, Tidhar A, Zauberman A, Aftalion M, Gur D, Fogel I, Chitlaru T, Flashner Y, Mamroud E.

J Infect Dis. 2016 Sep 15;214(6):970-7. doi: 10.1093/infdis/jiw290. Epub 2016 Jul 11.

PMID:
27402776
11.

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.

Vagima Y, Zauberman A, Levy Y, Gur D, Tidhar A, Aftalion M, Shafferman A, Mamroud E.

PLoS Pathog. 2015 May 14;11(5):e1004893. doi: 10.1371/journal.ppat.1004893. eCollection 2015 May.

12.

YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].

Zauberman A, Flashner Y, Levy Y, Vagima Y, Tidhar A, Cohen O, Bar-Haim E, Gur D, Aftalion M, Halperin G, Shafferman A, Mamroud E.

PLoS One. 2013 Dec 16;8(12):e83560. doi: 10.1371/journal.pone.0083560. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/0ec1f217-4e7a-4dee-9a71-1076a3ac73f1.

13.

Early sensing of Yersinia pestis airway infection by bone marrow cells.

Vagima Y, Levy Y, Gur D, Tidhar A, Aftalion M, Abramovich H, Zahavy E, Zauberman A, Flashner Y, Shafferman A, Mamroud E.

Front Cell Infect Microbiol. 2012 Nov 26;2:143. doi: 10.3389/fcimb.2012.00143. eCollection 2012.

14.

T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.

Levy Y, Flashner Y, Tidhar A, Zauberman A, Aftalion M, Lazar S, Gur D, Shafferman A, Mamroud E.

Vaccine. 2011 Sep 16;29(40):6866-73. doi: 10.1016/j.vaccine.2011.07.059. Epub 2011 Jul 29.

PMID:
21803090
15.

The search for early markers of plague: evidence for accumulation of soluble Yersinia pestis LcrV in bubonic and pneumonic mouse models of disease.

Flashner Y, Fisher M, Tidhar A, Mechaly A, Gur D, Halperin G, Zahavy E, Mamroud E, Cohen S.

FEMS Immunol Med Microbiol. 2010 Jul 1;59(2):197-206. doi: 10.1111/j.1574-695X.2010.00687.x. Epub 2010 Apr 19.

16.

The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague.

Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, Aftalion M, Elhanany E, Zvi A, Shafferman A, Mamroud E.

PLoS One. 2009 Sep 14;4(9):e7023. doi: 10.1371/journal.pone.0007023.

17.

Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Zauberman A, Tidhar A, Levy Y, Bar-Haim E, Halperin G, Flashner Y, Cohen S, Shafferman A, Mamroud E.

PLoS One. 2009 Jun 16;4(6):e5938. doi: 10.1371/journal.pone.0005938.

18.

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.

Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.

Vaccine. 2008 Mar 20;26(13):1616-25. doi: 10.1016/j.vaccine.2008.01.033. Epub 2008 Feb 6.

PMID:
18304706
19.

Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.

Steinberger-Levy I, Zahavy E, Cohen S, Flashner Y, Mamroud E, Aftalion M, Gur D, Ber R.

Adv Exp Med Biol. 2007;603:339-50.

PMID:
17966430
20.

Disparity between Yersinia pestis and Yersinia enterocolitica O:8 in YopJ/YopP-dependent functions.

Zauberman A, Velan B, Mamroud E, Flashner Y, Shafferman A, Cohen S.

Adv Exp Med Biol. 2007;603:312-20.

PMID:
17966427
21.

Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration.

Velan B, Bar-Haim E, Zauberman A, Mamroud E, Shafferman A, Cohen S.

Infect Immun. 2006 Nov;74(11):6365-76. Epub 2006 Aug 21.

22.

Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis.

Zauberman A, Cohen S, Mamroud E, Flashner Y, Tidhar A, Ber R, Elhanany E, Shafferman A, Velan B.

Infect Immun. 2006 Jun;74(6):3239-50.

23.

Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Lazar S, Zvi A, Bino T, Ariel N, Velan B, Shafferman A, Cohen S.

Infect Immun. 2004 Feb;72(2):908-15.

24.

Development of an improved selective agar medium for isolation of Yersinia pestis.

Ber R, Mamroud E, Aftalion M, Tidhar A, Gur D, Flashner Y, Cohen S.

Appl Environ Microbiol. 2003 Oct;69(10):5787-92.

25.

A new selective medium provides improved growth and recoverability of Yersinia pestis.

Ber R, Mamroud E, Aftalion M, Gur D, Tidhar A, Flashner Y, Cohen S.

Adv Exp Med Biol. 2003;529:467-8. No abstract available.

PMID:
12756811
26.

Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.

Mamroud E, Flashner Y, Tidhar A, Ber R, Gur D, Aftalion M, Lazar S, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:425-30. No abstract available.

PMID:
12756803
27.

Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.

Grosfeld H, Bino T, Flashner Y, Ber R, Mamroud E, Lustig S, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:423-4. No abstract available.

PMID:
12756802
28.

Identification of genes involved in Yersinia pestis virulence by signature-tagged mutagenesis.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Zvi A, Ariel N, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:31-3. No abstract available.

PMID:
12756723
29.

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B.

Infect Immun. 2003 Jan;71(1):374-83.

Supplemental Content

Loading ...
Support Center